Compare MDXG & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | CRAI |
|---|---|---|
| Founded | 2006 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | N/A | 1998 |
| Metric | MDXG | CRAI |
|---|---|---|
| Price | $7.23 | $203.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $239.00 |
| AVG Volume (30 Days) | ★ 755.0K | 79.8K |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | N/A | ★ 34.79 |
| EPS | 0.27 | ★ 8.34 |
| Revenue | $393,442,000.00 | ★ $731,055,000.00 |
| Revenue This Year | $19.13 | $10.57 |
| Revenue Next Year | $2.11 | $3.66 |
| P/E Ratio | $26.86 | ★ $24.13 |
| Revenue Growth | ★ 14.77 | 8.69 |
| 52 Week Low | $5.79 | $152.57 |
| 52 Week High | $9.71 | $214.66 |
| Indicator | MDXG | CRAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 71.29 |
| Support Level | $6.62 | $175.15 |
| Resistance Level | $7.06 | $190.92 |
| Average True Range (ATR) | 0.23 | 5.57 |
| MACD | 0.05 | 2.69 |
| Stochastic Oscillator | 91.11 | 86.00 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.